The gut microbiome, mild cognitive impairment, and probiotics: A randomized clinical trial in middle-aged and older adults

Coming Soon.

Year: 2022

Reference: Aljumaah, M. R., Bhatia, U., Roach, J., Gunstad, J., & Azcarate Peril, M. A. (2022). The gut microbiome, mild cognitive impairment, and probiotics: A randomized clinical trial in middle-aged and older adults. Clinical nutrition (Edinburgh, Scotland), 41(11), 2565–2576. https://doi.org/10.1016/j.clnu.2022.09.012

Related Studies

Methionine ameliorates intestinal injury in senescence-accelerated mouse prone-8 mice by reducing sulfate-reducing bacteria and enhancing barrier function

This research investigates the impact of varying dietary methionine levels on intestinal integrity and gut microbiota in aging mice, utilizing the SAMP8 mouse model specifically. The study involved three dietary groups: a methionine-restricted group, a normal group, and a methionine-supplemented group, with SAMP1 mice serving as the control group. Key parameters evaluated included intestinal barrier function, colon […]

Crosstalk between the gut microbiota and the brain: An update on neuroimaging findings

Liu et al. (2019) recognised that the mechanisms underlying the association between the alterations in gut microbiota (GM) with neurodevelopmental, neurodegenerative, and psychiatric disorders were mainly based on parallel CNS, endocrine, and immune-related molecular pathways that interact with each other. Due to the scarcity of data on how structural and functional changes in the brain […]